share_log

Merit Medical Systems (NASDAQ:MMSI) Raised to "Strong-Buy" at StockNews.com

Merit Medical Systems (NASDAQ:MMSI) Raised to "Strong-Buy" at StockNews.com

优点医疗系统公司(纳斯达克代码:MMSI)在StockNews.com被上调至“强力买入”
kopsource ·  2023/01/06 02:41

StockNews.com upgraded shares of Merit Medical Systems (NASDAQ:MMSI – Get Rating) from a buy rating to a strong-buy rating in a report released on Tuesday morning.

在周二上午发布的一份报告中,斯托克新闻网将默立特医疗系统公司(纳斯达克代码:MMSI-GET Rating)的股票评级从买入上调至强力买入。

Other equities research analysts also recently issued reports about the stock. Raymond James raised their target price on shares of Merit Medical Systems from $71.00 to $72.00 and gave the company an outperform rating in a research note on Thursday, October 27th. Canaccord Genuity Group downgraded shares of Merit Medical Systems from a buy rating to a hold rating and lowered their target price for the company from $73.00 to $72.00 in a research note on Tuesday, December 20th. TheStreet raised shares of Merit Medical Systems from a c+ rating to a b- rating in a report on Friday, September 16th. Piper Sandler raised their price target on shares of Merit Medical Systems from $70.00 to $73.00 in a report on Thursday, October 27th. Finally, Canaccord Genuity Group raised their price target on shares of Merit Medical Systems from $69.00 to $73.00 in a report on Monday, November 7th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Merit Medical Systems presently has a consensus rating of Buy and a consensus price target of $73.50.

其他股票研究分析师最近也发布了有关该股的报告。雷蒙德·詹姆斯在10月27日周四的一份研究报告中将Merit Medical Systems的目标价从71.00美元上调至72.00美元,并给出了该公司表现优于大盘的评级。在12月20日星期二的一份研究报告中,Canaccel Genuity Group将Merit Medical Systems的股票评级从买入下调至持有评级,并将该公司的目标价从73.00美元下调至72.00美元。华尔街在9月16日星期五的一份报告中将Merit Medical Systems的股票评级从C+上调至B-。派珀·桑德勒在10月27日星期四的一份报告中将他们对Merit医疗系统公司股票的目标价从70.00美元上调至73.00美元。最后,在11月7日星期一的一份报告中,Canaccel Genuity Group将Merit Medical Systems的股票目标价从69.00美元上调至73.00美元。一名投资分析师对该股的评级为持有,四名分析师给予了买入评级,一名分析师对该公司发出了强烈的买入评级。根据MarketBeat的数据,Merit Medical Systems目前的共识评级为买入,共识目标价为73.50美元。

Get
到达
Merit Medical Systems
优点医疗系统
alerts:
警报:

Merit Medical Systems Price Performance

优点医疗系统性价比

NASDAQ MMSI opened at $70.42 on Tuesday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.19 and a current ratio of 2.35. The firm's 50 day moving average price is $70.42 and its 200-day moving average price is $61.85. Merit Medical Systems has a 52-week low of $50.46 and a 52-week high of $76.14. The company has a market cap of $4.01 billion, a PE ratio of 65.20, a P/E/G ratio of 2.24 and a beta of 1.01.

纳斯达克MMSI周二开盘报70.42美元。该公司的负债权益比率为0.19,速动比率为1.19,流动比率为2.35。该公司的50日移动均线价格为70.42美元,200日移动均线价格为61.85美元。优点医疗系统公司的股价为50.46美元,为52周低点,52周高点为76.14美元。该公司市值为40.1亿美元,市盈率为65.20倍,市盈率为2.24倍,贝塔系数为1.01。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last announced its earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.11. The company had revenue of $287.18 million during the quarter, compared to the consensus estimate of $273.03 million. Merit Medical Systems had a net margin of 5.43% and a return on equity of 14.14%. Sell-side analysts forecast that Merit Medical Systems will post 2.57 EPS for the current fiscal year.
优点医疗系统公司(纳斯达克代码:MMSI-GET Rating)最近一次公布财报是在10月26日星期三。这家医疗器械供应商公布本季度每股收益为0.64美元,比普遍预期的0.53美元高出0.11美元。该公司本季度营收为2.8718亿美元,而市场普遍预期为2.7303亿美元。优点医疗系统公司的净利润率为5.43%,股本回报率为14.14%。卖方分析师预测,Merit Medical Systems本财年每股收益将达到2.57欧元。

Institutional Inflows and Outflows

机构资金流入和流出

Several institutional investors have recently made changes to their positions in MMSI. BlackRock Inc. raised its holdings in shares of Merit Medical Systems by 6.8% during the third quarter. BlackRock Inc. now owns 9,704,654 shares of the medical instruments supplier's stock worth $548,409,000 after purchasing an additional 617,129 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Merit Medical Systems by 6.0% during the third quarter. Vanguard Group Inc. now owns 6,700,655 shares of the medical instruments supplier's stock worth $378,653,000 after purchasing an additional 377,858 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Merit Medical Systems by 61.4% during the third quarter. Bank of New York Mellon Corp now owns 950,734 shares of the medical instruments supplier's stock worth $53,727,000 after purchasing an additional 361,635 shares during the last quarter. Eagle Asset Management Inc. raised its holdings in shares of Merit Medical Systems by 48.4% during the second quarter. Eagle Asset Management Inc. now owns 712,135 shares of the medical instruments supplier's stock worth $38,647,000 after purchasing an additional 232,211 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH purchased a new position in Merit Medical Systems in the third quarter valued at $12,592,000. Hedge funds and other institutional investors own 95.38% of the company's stock.

几家机构投资者最近改变了他们在MMSI的头寸。贝莱德股份有限公司在第三季度增持了6.8%的功德医疗系统股份。贝莱德股份有限公司在上个季度增持了617,129股后,现在持有这家医疗器械供应商价值548,409,000美元的股票9,704,654股。先锋集团(Vanguard Group Inc.)在第三季度增持了Merit Medical Systems的股票6.0%。先锋集团现在持有这家医疗器械供应商6,700,655股股票,价值378,653,000美元,上个季度又购买了377,858股。纽约梅隆银行(Bank Of New York Mellon Corp)在第三季度增持了61.4%的Merit Medical Systems股票。纽约梅隆银行(Bank Of New York Mellon Corp)目前持有这家医疗器械供应商950,734股票,价值53,727,000美元,此前该公司在上一季度额外购买了361,635股票。Eagle Asset Management Inc.在第二季度增持了48.4%的Merit Medical Systems股票。Eagle Asset Management Inc.现在持有这家医疗器械供应商712,135股股票,价值38,647,000美元,此前该公司在上个季度又购买了232,211股票。最后,华盛顿堡投资顾问公司(Fort Washington Investment Advisors Inc.)在第三季度以12,592,000美元收购了Merit Medical Systems的一个新头寸。对冲基金和其他机构投资者持有该公司95.38%的股票。

About Merit Medical Systems

关于功德医疗系统公司

(Get Rating)

(获取评级)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

优点医疗系统公司设计、开发、制造和营销用于介入、诊断和治疗程序的一次性医疗产品,主要用于心脏病学、放射学、肿瘤学、危重护理和内窥镜检查。该公司在心血管和内窥镜两个领域开展业务。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • Can Chip Gear Maker Lam Continue Its Rally As Earnings Slow?
  • Bed Bath & Beyond Stock Crumbles 24% On Possible Bankruptcy News
  • Why Is Kraft Heinz Moving Higher
  • What will this mean for the Devon Energy stock price this year?
  • Nio Stock, Is This The Bottom ?
  • 免费获取StockNews.com关于Merit Medical Systems(MMSI)的研究报告
  • 芯片齿轮制造商LAM能否在盈利放缓的情况下继续上涨?
  • Bed Bath&Beyond股票因可能破产消息暴跌24%
  • 为什么卡夫亨氏走得更高
  • 这对今年德文能源的股价意味着什么?
  • 蔚来股,这是底部吗?

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新闻和评级的优点医疗系统每日-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Merit Medical Systems和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发